The increase in price target from $50 to $60 by a reputable analyst firm like HC Wainwright & Co. suggests a strong confidence in Crinetics Pharmaceuticals' future performance. This endorsement is likely to positively influence investor sentiment and potentially increase the stock price in the short term.